Chambers Research is conducted by 200 Research Analysts, across 200 jurisdictions and provides nearly 6,000 rankings tables. Annually we collect hundreds of thousands of responses from clients, the majority via in-depth interview. Learn more about our methodology.
This content is provided by Andrew W Cheng
Andrew’s practice has focused primarily on representing lenders, borrowers and private equity sponsors in leveraged finance transactions, including syndicated senior secured credit agreements, Rule 144A high-yield offerings and convertible note offerings, in both non-distressed and distressed situations. During the past year, Andrew has represented ad hoc groups of lenders in several highly publicized and innovative priming, amend-and-extend and first-out/second-out facilities. He has also recently represented borrowers and lenders in cutting edge debt financings in the biotech space.